Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(13%)

Phase Distribution

Ph phase_3
2
25%
Ph phase_4
4
50%
Ph phase_1
2
25%

Phase Distribution

2

Early Stage

0

Mid Stage

6

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
2(25.0%)
Phase 3Large-scale testing
2(25.0%)
Phase 4Post-market surveillance
4(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(6)
Terminated(1)
Other(1)

Detailed Status

Completed6
Terminated1
Suspended1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
85.7%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (25.0%)
Phase 32 (25.0%)
Phase 44 (50.0%)

Trials by Status

terminated113%
completed675%
suspended113%

Recent Activity

0 active trials
Showing 5 of 8
suspendedphase_4

An Open-Label Tolerability and Exploratory Efficacy Study of Zonisamide for Dyskinesias in Parkinson's Disease

NCT03034538
completedphase_4

Open Label, Zonegran (Zonisamide) In Partial Onset Seizures

NCT00215592
completedphase_3

Efficacy Trial of Zonisamide for Myoclonus Dystonia

NCT01806805
terminatedphase_4

Efficacy and Safety of an add-on Treatment With Zonisamide in Adults With Focal Epileptic Seizures With or Without Secondary Generalization

NCT00165828
completedphase_4

Zonegran for the Treatment of Weight Gain Associated With Psychotropic Medication Use: A Placebo-Controlled Trial

NCT00203450
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT03034538Phase 4

An Open-Label Tolerability and Exploratory Efficacy Study of Zonisamide for Dyskinesias in Parkinson's Disease

Suspended
NCT00215592Phase 4

Open Label, Zonegran (Zonisamide) In Partial Onset Seizures

Completed
NCT01806805Phase 3

Efficacy Trial of Zonisamide for Myoclonus Dystonia

Completed
NCT00165828Phase 4

Efficacy and Safety of an add-on Treatment With Zonisamide in Adults With Focal Epileptic Seizures With or Without Secondary Generalization

Terminated
NCT00203450Phase 4

Zonegran for the Treatment of Weight Gain Associated With Psychotropic Medication Use: A Placebo-Controlled Trial

Completed
NCT00221442Phase 3

Zonegran in the Treatment of Binge Eating Disorder Associated With Obesity

Completed
NCT01161966Phase 1

Bioequivalence Study of Zonisamide Capsules 100 mg of Dr.Reddy's Laboratories Limited Under Fasting Conditions

Completed
NCT01161979Phase 1

Bioequivalence Study of Zonisamide Capsules 100 mg of Dr.Reddy's Laboratories Limited Under Fed Conditions

Completed

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8